scholarly article | Q13442814 |
P50 | author | Babette S Zemel | Q87885758 |
Robert N Baldassano | Q89270894 | ||
Michelle R Denburg | Q95993929 | ||
Meena Thayu | Q114398285 | ||
Lindsay M Griffin | Q117265528 | ||
Rita M Herskovitz | Q117265529 | ||
P2093 | author name string | Arthur M Lee | |
Mark D DeBoer | |||
Mary B Leonard | |||
Lee A Denson | |||
Jin Long | |||
Kirabo Herbert | |||
P2860 | cites work | TNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding | Q28366349 |
Mice with infectious colitis exhibit linear growth failure and subsequent catch-up growth related to systemic inflammation and IGF-1. | Q30252705 | ||
Systemic inflammation, growth factors, and linear growth in the setting of infection and malnutrition | Q30275779 | ||
Increases in Sex Hormones during Anti-Tumor Necrosis Factor α Therapy in Adolescents with Crohn's Disease | Q30277350 | ||
Bone Mineral Accrual Is Associated With Parathyroid Hormone and 1,25-Dihydroxyvitamin D Levels in Children and Adolescents | Q30278911 | ||
Improvements in Bone Density and Structure during Anti-TNF-α Therapy in Pediatric Crohn's Disease | Q30300036 | ||
Changes in vitamin D-related mineral metabolism after induction with anti-tumor necrosis factor-α therapy in Crohn's disease | Q30393774 | ||
Lean mass deficits, vitamin D status and exercise capacity in children and young adults after Fontan palliation | Q30414856 | ||
Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp | Q30448178 | ||
Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit | Q32127649 | ||
DXA estimates of vertebral volumetric bone mineral density in children: potential advantages of paired posteroanterior and lateral scans | Q33255198 | ||
The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race | Q33274786 | ||
Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children | Q33526749 | ||
Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults | Q33531394 | ||
Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study | Q34019655 | ||
Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease | Q34023127 | ||
Assessment of dual-energy X-ray absorptiometry measures of bone health in pediatric chronic kidney disease | Q34164661 | ||
Growth problems in children with IBD. | Q34426164 | ||
Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. | Q34450703 | ||
Sex differences in statural growth impairment in Crohn's disease: role of IGF-1. | Q35106293 | ||
Unbound (bioavailable) IGF1 enhances somatic growth. | Q35232634 | ||
Insulin Resistance Negatively Influences the Muscle-Dependent IGF-1-Bone Mass Relationship in Premenarcheal Girls | Q35843439 | ||
Changes in trabecular bone density in incident pediatric Crohn's disease: a comparison of imaging methods | Q35939987 | ||
Bone density and structure in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantation | Q35966135 | ||
Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation | Q36906942 | ||
Effect of Low-Magnitude Mechanical Stimuli on Bone Density and Structure in Pediatric Crohn's Disease: A Randomized Placebo-Controlled Trial | Q36963693 | ||
Long-term inflammation and glucocorticoid therapy impair skeletal modeling during growth in childhood Crohn disease | Q37071224 | ||
Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions | Q37283796 | ||
An evidence-based comparison of operational criteria for the presence of sarcopenia | Q37709589 | ||
Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis | Q40424076 | ||
Development and validation of a pediatric Crohn's disease activity index | Q40749458 | ||
Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone | Q43917296 | ||
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease | Q59310001 | ||
The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease | Q63466830 | ||
Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation | Q73941872 | ||
Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis | Q74631174 | ||
Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3 | Q78767560 | ||
Effects of Increased Muscle Mass on Bone in Male Mice Overexpressing IGF-I in Skeletal Muscles | Q79180381 | ||
Validation of a self-administered instrument to assess stage of adolescent development | Q86912908 | ||
Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions | Q87580460 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | TNF inhibitor | Q1536078 |
P304 | page(s) | 936-945 | |
P577 | publication date | 2018-01-10 | |
P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
P1476 | title | Increases in IGF-1 after Anti-TNF-α Therapy are Associated with Bone and Muscle Accrual in Pediatric Crohn's Disease | |
P478 | volume | 103 |
Search more.